Breaking
[TENNIS]Tennis.com Lived And Died With The Internet[APPLE]Popular travel tech find hits its lowest price of the year[LIGHTPHONE]The Light Flip Is the Stylish Dumb Flip Phone of Your Dreams[TEXAS TEACHER RETIREMENT SYSTEM]How Texas Teachers is mapping 5 AI themes for ‘significant’ generational opportunity[VIRGINIA]Woman faces employment barriers despite new clean slate law[TENNIS]Tennis.com Lived And Died With The Internet[APPLE]Popular travel tech find hits its lowest price of the year[LIGHTPHONE]The Light Flip Is the Stylish Dumb Flip Phone of Your Dreams[TEXAS TEACHER RETIREMENT SYSTEM]How Texas Teachers is mapping 5 AI themes for ‘significant’ generational opportunity[VIRGINIA]Woman faces employment barriers despite new clean slate law

Medication

1 stories

AllDRUGCHANNELSIOWA STATE UNIVERSITYUNIQUEPHARMACEUTICALNOVONORDISKELILILLYAMGENFDAMERCKHEALTHPHARMACEUTICALSTGMCENVIRONMENT CANADAAKSTONPHARMACYTELANGANA DCAIMHDEAMHRAAMBLEPLASTICSURGERYAKSTON BIOSCIENCESTLCFFXNOWLIPFENDRAHSCPREP4ALLMEDSCAPEGSKFRACTYLHEALTHTRUMPRXTELEHEALTHGLENMARKMEDICAREEUROPEAN COMMISSIONHMSACVSCAR EMARKONCOLOGYKETABONPHARMACEUTICALLUPINLEQEMBIASCENSION
A chart showing the divergence between manufacturer list prices and net revenues for top pharmaceutical companies.
DRUGCHANNELS1h ago

2025 Gross-to-Net Realities at Eight Top Drugmakers: The Net Pricing Drug Channel Emerges

New data on drug pricing for 2025 highlights a clear shift in how pharmaceutical manufacturers manage market access. Examining eight top companies, including Sanofi and Bristol Myers Squibb, we see that list prices conti…

← BACK TO ALL HEALTH NEWS